GLAXO · GlaxoSmithKline Pakistan Limited
366.89
PKRUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Rs116.84B
PE
12.40
EV/EBITDA
6.8
DIV Yield
4.4%
Payout Ratio
54%
MQV Rating
5Very Weak
As at 25/06/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 100
- HALO 200
- HALO All
- Recent Price downgrade
Key Fundamentals
EPS 3 yr Growth
307.10%
EBITDA Margin
25.80%
Operating Cashflow
Rs9,182m
Free Cash Flow Return
29.40%
ROIC
32.10%
Interest Coverage
145.80
Quick Ratio
1.40
Performance
52 weeks range
Low 293.09 - 459.94
Trade Value (12mth)
US$124,144.00
1 week
-3.19%
1 month
9.42%
YTD
-8.29%
1 year
-3.08%
All time high
481.00
Additional Data
Shares Outstanding (Fully Diluted)
318m
HALO Sector
Healthcare
Next Company Report Date
03-Mar-27
Next Ex Dividend Date
24-Apr-26
Next Dividend Pay Date
06-May-26
Reporting Currency
PKR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Weak
Growth
Earnings
Neutral
Dividends
Neutral
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
